Form 4: MongoDB Director Sells $6.7M in Stock Under 10b5-1 Plan
Insider Transaction Report
MongoDB Director Dwight A. Merriman sold 15,990 shares of common stock for approximately $6.7 million in December 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- Dwight A. Merriman, a Director of MongoDB, Inc. (MDB), reported multiple sales of the company's common stock.
- A total of 15,990 shares were sold across transactions on December 12, 2025, and December 15, 2025.
- The sales were executed at weighted average prices ranging from $416.78 to $420.04 per share.
- All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Merriman.
- Following these transactions, Mr. Merriman directly beneficially owns 1,041,316 shares of Common Stock.
- Indirect beneficial ownership includes 496,896 shares held by The Dwight A. Merriman 2012 Trust for the benefit of his children, and 83,845 shares held by the Dwight A. Merriman Charitable Foundation.
Sentiment
Score: 3
Explanation: The sentiment is moderately negative due to significant insider selling by a director, even though it was pre-planned under a 10b5-1 plan. While the plan mitigates the immediate negative signal, it still represents a reduction in insider exposure.
Positives
- The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-scheduled sales rather than reactive selling based on new, non-public information, which provides transparency.
Negatives
- A director selling a significant number of shares (15,990 shares totaling approximately $6.7 million) can be perceived by the market as a signal that the insider believes the stock is fully valued or that they are diversifying their portfolio.
Risks
- The market may interpret significant insider selling as a potential lack of confidence in the company's near-term growth prospects, which could put downward pressure on the stock price.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report does not provide specific industry context or analysis of broader industry trends.
Related Party Transactions
- Shares held by The Dwight A. Merriman 2012 Trust are for the benefit of the Reporting Person's children.
- Shares held by the Dwight A. Merriman Charitable Foundation, where the Reporting Person has voting and investment power but no pecuniary interest.
Stakeholder Impact
- Shareholders may view the significant insider selling as a negative signal, potentially influencing their investment decisions or the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 12/12/2025 | Sale of 10,000 shares of Common Stock by Dwight A. Merriman. |
| 12/15/2025 | Multiple sales totaling 5,990 shares of Common Stock by Dwight A. Merriman, held indirectly by a trust. |
| 12/16/2025 | Date the Form 4 filing was signed. |
Recommendation
holdWhile the sales by Director Dwight A. Merriman were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned diversification or liquidity event rather than a reaction to new negative information, the sheer volume of shares sold (approximately $6.7 million) is notable. Significant insider selling, even if planned, can be interpreted by the market as a signal that the insider believes the stock is fully valued or that future growth may be moderating. Investors should 'hold' and monitor future insider activity, company performance, and broader market conditions for MongoDB, Inc. before making further investment decisions.
Keywords
MongoDB, MDB, insider trading, Form 4, stock sale, director, Dwight Merriman, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.